Company: IPSC
Filing Date: 2025-11-21
Form Type: PRE 14A
Source: 0001104659-25-114992
Chunk: 0

Company: Century Therapeutics, Inc.
Filing Date: 2025-11-21
Form: PRE 14A
Chunk 0
---
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ☒ Filed by the Registrant ☐ Filed by a Party other than the Registrant

| ​ | ​ | Check the appropriate box: |   |   |                                                                                 | ​ | ​ |
| ​ | ​ | ☒                          | ​ | ​ | Preliminary Proxy Statement                                                     | ​ | ​ |
| ​ | ​ | ☐                          | ​ | ​ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | ​ | ​ |
| ​ | ​ | ☐                          | ​ | ​ | Definitive Proxy Statement                                                      | ​ | ​ |
| ​ | ​ | ☐                          | ​ | ​ | Definitive Additional Materials                                                 | ​ | ​ |
| ​ | ​ | ☐                          | ​ | ​ | Soliciting Material under §240.14a-12                                           | ​ | ​ |

CENTURY THERAPEUTICS, INC. (Name of Registrant as Specified In Its Charter)

| ​ | ​ | Payment of Filing Fee (Check all boxes that apply): |   |   |                                                                                                     | ​ | ​ |
| ​ | ​ | ☒                                                   | ​ | ​ | No fee required                                                                                     | ​ | ​ |
| ​ | ​ | ☐                                                   | ​ | ​ | Fee paid previously with preliminary materials                                                      | ​ | ​ |
| ​ | ​ | ☐                                                   | ​ | ​ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 | ​ | ​ |

PRELIMINARY PROXY STATEMENT SUBJECT TO COMPLETION, DATED NOVEMBER 21, 2025
In accordance with Rule 14a-6(d) under Regulation 14A, please be advised that Century Therapeutics, Inc.
intends to release definitive copies of this Proxy Statement to stockholders on or about
December 2, 2025. 25 North 38th Street, 11th Floor
Philadelphia, Pennsylvania 19104 2026 SPECIAL MEETING OF STOCKHOLDERS
To be Held on January 22, 2026 , 2025 Dear Stockholder: We are pleased to invite you to attend a Special Meeting of